Friday, July 17 closed a busy week of earnings and analyst activity, with fresh upgrades landing across financials, megacap tech, industrial distribution, specialty chemicals, and diversified industrials. Q2 earnings roll on into a heavier week ahead, with major tech and industrial names on deck. The backdrop remains Chair Kevin Warsh's June 17 FOMC hold at 3.50%–3.75% and a CME FedWatch reading pricing roughly an 80% probability of zero rate cuts through year-end 2026. Five names drew fresh Buy signals for Monday, July 20.
Morgan Stanley (MS) — Freedom Broker upgrades the wealth and IB leader to Buy at $245
Morgan Stanley is one of the largest US investment banks, combining a top-tier institutional securities franchise with a leading wealth-management platform following the E*TRADE acquisition, and pairing that with a growing investment-management business. On July 17, Freedom Broker analyst Mikhail Paramonov upgraded the stock from Hold to Buy and lifted his target from $200 to $245. The upgrade joins BMO Capital's Brennan Hawken at Outperform $250 and Evercore ISI's Glenn Schorr at Outperform $240 from the same session, both raised on Q2 results.
Shares traded at $214.98 midday July 17, down 1.55%, with a market cap of $339.1 billion and a trailing P/E of 17.38. Trailing EPS was $12.37 and the dividend yield is roughly 2%. The 52-week range is $136.17 to $232.25, near cycle highs after the earnings run. The consensus rating is Buy, with 7 of 12 analysts bullish (58.3%), an average target of $238.50, a median of $242.50, a high of $262, and a low of $195.
Risks: Investment-banking fees remain sensitive to deal-flow cycles that can turn quickly with capital-markets volatility; wealth-management net new asset growth is slowing from the post-E*TRADE peak; a sustained equity drawdown would compress AUM-linked revenue; and Wells Fargo's Mike Mayo holds Equal-Weight at $200, well below the current share price.
Apple (AAPL) — HSBC flips to Buy with a $366 target
Apple designs and sells iPhones, Macs, iPads, wearables, and services across a globally distributed retail and channel network, with the Services segment now a high-margin, roughly $100 billion annualized business anchoring the model as hardware growth matures. On July 17, HSBC analyst Nicolas Cote-Colisson upgraded the stock from Hold to Buy and lifted his target from $260 to $366 — a $106 price-target jump reflecting a more constructive stance on the iPhone upgrade cycle and AI-driven services attach. Citigroup's Atif Malik holds Buy at $365 and Evercore ISI's Amit Daryanani holds Outperform at $365.
Shares traded at $333.96 midday July 17, up 0.21%, with a market cap of $4.9 trillion and a trailing P/E of 40.33. Trailing EPS was $8.28 and the company pays no material dividend. The 52-week range is $201.50 to $334.98, at cycle highs. The consensus rating is Buy, with 10 of 14 analysts bullish (71.4%), an average target of $336.86, a median of $355, a high of $400, and a low of $253.
Risks: iPhone unit growth has flattened and consumer replacement cycles have extended; regulatory pressure on App Store economics from EU and US actions continues to build; the trailing P/E of 40 leaves limited cushion if Services growth decelerates; and Barclays' Tim Long holds Underweight at $253, still the Street low.
Ferguson Enterprises (FERG) — Zelman & Associates initiates the plumbing distributor at Outperform
Ferguson Enterprises is the largest US distributor of plumbing, HVAC, and waterworks products, serving residential, commercial, and civil-infrastructure end markets through more than 1,700 branches across the United States and Canada. On July 17, Zelman & Associates started coverage at Outperform with a $285 target, joining Barclays' Matthew Bouley at Overweight $297 and RBC Capital's Mike Dahl at Outperform $281.
Shares traded at $231.65 midday July 17, down 1.05%, with a market cap of $44.9 billion and a trailing P/E of 23.69. Trailing EPS was $9.78 and the dividend yield is roughly 2%. The 52-week range is $207.64 to $271.64. The consensus rating is Buy, with 8 of 11 analysts bullish (72.7%), an average target of $273.18, a median of $280, a high of $300, and a low of $245.
Risks: Residential remodeling and new-construction volumes are sensitive to mortgage rates that the FOMC has kept restrictive; commercial construction backlogs are decelerating in select verticals; competition from Home Depot Pro and Core & Main is intensifying in waterworks; and Goldman Sachs' Suhasini Varanasi downgraded the stock to Neutral at $265 on July 7 on valuation.
Ecolab (ECL) — Oppenheimer flips to Outperform on the water and hygiene compounder
Ecolab is the global leader in water, hygiene, and infection-prevention products and services, serving foodservice, healthcare, industrial, and energy end markets with a razor-and-blade model that pairs equipment installations with recurring chemical and service revenue. On July 17, Oppenheimer analyst Scott Schneeberger upgraded the stock from Perform to Outperform with a $320 target, joining Deutsche Bank's David Begleiter at Buy $335 and RBC Capital's Ashish Sabadra at Outperform $337.
Shares traded at $272.43 midday July 17, down 1.19%, with a market cap of $76.7 billion and a trailing P/E of 35.20. Trailing EPS was $7.74 and the dividend yield is roughly 1%. The 52-week range is $243.15 to $309.27. The consensus rating is Strong Buy, with 13 of 14 analysts bullish (92.9%), an average target of $323, a median of $332.50, a high of $345, and a low of $275.
Risks: Foodservice and hospitality volumes track discretionary consumer spending that can soften with unemployment; raw-material costs for surfactants and specialty chemistries remain a periodic margin swing factor; capex on water infrastructure by industrial customers can pause during macro slowdowns; and UBS's Joshua Spector holds Neutral at $299, below the average target.
3M (MMM) — JP Morgan upgrades the diversified industrial to Overweight at $180
3M is a diversified industrial manufacturer with roughly 60,000 products spanning safety and industrial, transportation and electronics, and consumer segments, and continues to work through litigation settlements and the Solventum spinoff completed in 2024. On July 17, JP Morgan analyst Chigusa Katoku upgraded the stock from Neutral to Overweight with a $180 target. Wells Fargo's Joe O'Dea holds Overweight at $165 as a similar-tenor bullish view.
Shares traded at $160.50 midday July 17, down 0.78%, with a market cap of $83.7 billion and a trailing P/E of 19.29. Trailing EPS was $8.32 and the dividend yield is roughly 2%. The 52-week range is $139.34 to $177.41. The consensus rating is Buy, with 4 of 8 analysts bullish (50%), an average target of $169.38, a median of $173, a high of $190, and a low of $123.
Risks: Legacy PFAS and Combat Arms litigation exposures still overhang the balance sheet despite completed settlements; industrial volumes track global manufacturing PMIs that remain mixed; portfolio simplification post-Solventum is a multi-year lift; and RBC Capital's Deane Dray holds Underperform at $123, the current Street low.
Found this helpful? Share it with others.